Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dierk Thomas

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
Drug Design, Development and Therapy|January 27, 2011
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillationPatrick A Schweizer, Rüdiger Becker, Hugo A Katus, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 12, 2010
Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidinePatrick A Schweizer, Rüdiger Becker, Hugo A Katus, et al.
Journal of the American College of Cardiology|March 4, 2017
A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic DilationPatrick A Schweizer, Michael Koenen, Hugo A Katus, et al.
European Journal of Pharmacology|September 6, 2016
Antiarrhythmic gene therapy - will biologics replace catheters, drugs and devices?Patrick Lugenbiel, Patrick A Schweizer, Hugo A Katus, et al.
Current Opinion in Drug Discovery & Development|January 5, 2010
hERG: protein trafficking and potential for therapy and drug side effectsIngo Staudacher, Patrick A Schweizer, Hugo A Katus, et al.
Case Reports in Medicine|December 29, 2011
Systemic Embolization and Myocardial Infarction due to Clinically Unrecognized Left Atrial MyxomaBritta Vogel, Dierk Thomas, Derliz Mereles, et al.
The Journal of Biological Chemistry|August 12, 2011
Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERGAdrienne T Dennis, Drew Nassal, Isabelle Deschenes, et al.
Biochemical and Biophysical Research Communications|August 10, 2014
Vernakalant activates human cardiac K(2P)17.1 background K(+) channelsClaudia Seyler, Patrick A Schweizer, Edgar Zitron, et al.
Vascular Health and Risk Management|April 15, 2011
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillationConstanze Schmidt, Jana Kisselbach, Patrick A Schweizer, et al.
Journal of Electrocardiology|May 11, 2004
Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation fieldDierk Thomas, Rüdiger Becker, Hugo A Katus, et al.
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
Drug Design, Development and Therapy|January 27, 2011
Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillationPatrick A Schweizer, Rüdiger Becker, Hugo A Katus, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 12, 2010
Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidinePatrick A Schweizer, Rüdiger Becker, Hugo A Katus, et al.
Journal of the American College of Cardiology|March 4, 2017
A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic DilationPatrick A Schweizer, Michael Koenen, Hugo A Katus, et al.
European Journal of Pharmacology|September 6, 2016
Antiarrhythmic gene therapy - will biologics replace catheters, drugs and devices?Patrick Lugenbiel, Patrick A Schweizer, Hugo A Katus, et al.
Current Opinion in Drug Discovery & Development|January 5, 2010
hERG: protein trafficking and potential for therapy and drug side effectsIngo Staudacher, Patrick A Schweizer, Hugo A Katus, et al.
Case Reports in Medicine|December 29, 2011
Systemic Embolization and Myocardial Infarction due to Clinically Unrecognized Left Atrial MyxomaBritta Vogel, Dierk Thomas, Derliz Mereles, et al.
The Journal of Biological Chemistry|August 12, 2011
Antidepressant-induced ubiquitination and degradation of the cardiac potassium channel hERGAdrienne T Dennis, Drew Nassal, Isabelle Deschenes, et al.
Biochemical and Biophysical Research Communications|August 10, 2014
Vernakalant activates human cardiac K(2P)17.1 background K(+) channelsClaudia Seyler, Patrick A Schweizer, Edgar Zitron, et al.
Vascular Health and Risk Management|April 15, 2011
The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillationConstanze Schmidt, Jana Kisselbach, Patrick A Schweizer, et al.
Journal of Electrocardiology|May 11, 2004
Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation fieldDierk Thomas, Rüdiger Becker, Hugo A Katus, et al.
Pageof 22